JENNIFER ROBERTS: Open Payments
NPI 1922258235 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 31 payments from 15 companies in 2025. Trend: 2023 $233 · 2024 $259 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $147 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| IDORSIA PHARMACEUTICALS US INC | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Corcept Therapeutics | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $27 |
| Viatris Specialty LLC | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: REXULTI, FANAPT, AUSTEDO XR, Quviviq, Korlym, Kerendia, SPRAVATO, JARDIANCE.
Industry payments across OK — which companies pay providers there.
